A carregar...
Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential
Treatment of patients with type 2 diabetes is directed against treating symptoms of hyperglycemia, minimizing the risk of hypoglycemia, and the risk of microvascular and macrovascular complications. The majority of patients with type 2 diabetes die from cardiovascular or cerebrovascular disease. Fut...
Na minha lista:
| Publicado no: | Ther Adv Chronic Dis |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5761941/ https://ncbi.nlm.nih.gov/pubmed/29344329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622317735283 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|